ABC | Volume 114, Nº4, April 2020

Original Article Güneş et al. Epicardial adipose tissue and insulin resistance Arq Bras Cardiol. 2020; 114(4):675-682 12. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Adams-Huet B, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes. 1996;45(12):1684-93. 13. ChandaliaM, AbateN, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab.1999;84(7):2329-35. 14. Sharma AM. Mediastinal fat, insulin resistance, and hypertension. Hypertension. 2004;44(2):117-8. 15. El-Assaad I, Al-Kindi SG, Saarel EV, Aziz PF. Lone pediatric atrial fibrillation in the United States: analysis of over 1500 cases. PediatrCardiol. 2017;38(5):1004–9. 16. Gunes H, Sokmen A, Kaya H, Gungor O, Kerkutluoglu M, Guzel FB, et al. Evaluation of Atrial Electromechanical Delay to Predict Atrial Fibrillation in Hemodialysis Patients. Medicina (Kaunas). 2018; 54(4): E58. 17. Kurt M, Tanboğa IH, Karakaş MF, Büyükkaya E, Akcay AB, Sen N, et al. The relationship between atrial electromechanical delay and P-wave dispersion with the presence and severity of metabolic syndrome. Turk Kardiyol Dern Ars. 2012;40(8):663-70. 18. Zehir R, Karabay CY, Kocabay G, Kalayci A, Kaymaz O, Aykan AC, et al. Assessment of atrial conduction time in patients with polycystic ovary syndrome. J Interv Card Electrophysiol.2014;41(2):137-43. 19. BarlowSE.ExpertCommitteerecommendationsre¬gardingtheprevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(suppl 4); p164-92. 20. Shashaj B, Luciano R, Contoli B, Morino GS, Spreghini MR, Rustico C, et al. Reference ranges of HOMA-IR in normal-weight and obese young Caucasians. Acta Diabetol. 2016;53(2):251-60. 21. Iacobellis G., Lonn E., Lamy A. Epicardial fat thickness and coronary artery diseasecorrelate independentlyofobesity. Int JCardiol.2011;146(3):452–4. 22. Castro AV, Kolka CM, Kim SP, Bergman RN. Obesity, insulin resistance, and comorbidities? Mechanisms of association. Arq Bras Endocrinol Metabol.2014;58(6):600-9. 23. Gobato AO, Vasques AC, Zambon MP, Barros Filho A, Hessel G. Metabolic syndrome and insulin resistance in obese adolescents. Rev Paul Pediatr. 2014;32(1):55-62. 24. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115:e500–3. 25. SouzaMS, Leme RB, Franco RR, Romaldini CC, Tumas R, Cardoso AL, et al. Metabolic syndrome in obese and overweight adolescents. Rev Paul Pediatr. 2007;25:214–20. 26. Juárez-López C, Klünder-Klünder M, Medina-Bravo P, Madrigal-Azcárate A, Mass-Díaz E, Flores-Huerta S. Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents. BMC Public Health. 2010 Jun 07;10:318 27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations inman. Diabetologia. 1985;28(7):412–9. 28. Cho ME, Craven TE, Cheung AK, Glasser SP, Rahman M, Soliman EZ, et al. SPRINT Study Research Group. The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial). J Clin Hypertens (Greenwich). 2017;19(11):1152-61. 29. Nyman K, Granér M, PentikäinenMO, Lundbom J, Hakkarainen A, Sirén R, et al. Metabolic syndrome associates with left atrial dysfunction. Nutr Metab Cardiovasc Dis. 2018;28(7):727-34. 30. De Sensi F, Costantino S, Limbruno U, Paneni F. Atrial fibrillation in the cardiometabolic patient. Minerva Med. 2019;110(2):157-67. 31. Temız F, Gunes H, Gunes H. Evaluation of atrial electromechanical delay in children with obesity Medicina (Kaunas). 2019; 55(6): E228. 32. Gastaldelli A, Basta G. Ectopic fat and cardiovascular disease: what is the link? Nutr Metab Cardiovasc Dis. 2010; 20(7):481–90. 33. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005;2(10):536-43. 34. Schejbal V. Epicardial fatty tissue of the right ventricle F morphology, morphometry,and functionalsignificance.Pneumologie.1989;43(9):490-9. 35. Marchington JM, Mattacks CA, Pond CM. Adipose tissue in themammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B.1989;94(2):225-32. 36. Iacobellis G, RibaudoMC, Assael F, Vecci E, Tiberti C, Zappaterreno A et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinicalparametersofmetabolicsyndrome:anew indicatorofcardiovascular risk. J Clin Endocrinol Metab. 2003;88(11):5163-8. 37. Iacobellis G, Leonetti F. Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab. 2005;90(11):6300-2. 38. Cikim AS, Topal E, Harputluoglu M, Keskin L, Zengin Z, Cikim K, et al. Epicardial adipose tissue, hepatic steatosis and obesity. J Endocrinol Invest. 2007; 30(6):459-64. 39. Okyay K, Balcioglu AS, Tavil Y, Tacoy G, Turkoglu S, Abaci A. A relationship between echocardiographic subepicardial adipose tissue and metabolic syndrome. Int J Cardiovasc Imaging. 2008;24(6):577-83. 40. Abaci A, Tascilar ME, Saritas T, Yozgat Y, Yesilkaya E, Kilic A,et al. Threshold value of subepicardial adipose tissue to detect insulin resistance in obese children. Int J Obes (Lond). 2009;33(4):440-6. 41. ElshorbagyHH, Fouda ER, Kamal NM, BassiounyMM, FathiWM. Evaluation of Epicardial Fat and Carotid Intima-Media Thickness in Obese Children. Iran J Pediatr. 2016;26(1):e2968. 42. Wu X, Han T, Gao J, Zhang Y, Zhao S, Sun R,et al. Association of Serum Calcium and Insulin Resistance With Hypertension Risk: A Prospective Population-Based Study. J AmHeart Assoc.2019;8(1):e009585. 43. Bamaiyi AJ, Woodiwiss AJ, Peterson V, Gomes M, Libhaber CD, Sareli P,et al. Insulin resistance influences the impact of hypertension on left ventricular diastolic dysfunction in a community sample. Clin Cardiol.2019;42(2):305-11. 44. Gastaldelli A, Morales MA, Marraccini P, Sicari R. The role of cardiac fat in insulin resistance. Curr Opin Clin Nutr Metab Care. 2012;15(6):523-8. 45. SolakY,AfsarB,VaziriND,AslanG,YalcinCE,CovicA,etal.Hypertensionasan autoimmuneand inflammatorydisease.HypertensRes.2016;39(8).567–73. 46. Jansen vanVuren E, Malan L, von Känel R, Lammertyn L, CockeranM, Malan NT. Longitudinal changes of cardiac troponin and inflammation reflect progressivemyocyte stretch and likelihood for hypertension in a Blackmale cohort: The SABPA study. Hypertens Res. 2019 ;42(5):708-16. 681